Most COVID-19 patients in the ICU suffer from lung problems. Many with acute respiratory distress syndrome and associated pulmonary hypertension.

Arginine vasopressin offers an advantage over norepinephrine as vasopressor in those patients, as it does not constrict pulmonary arteries when administered early in septic shock.


3 Practical Tools for Your Daily Work in the ICU for Download:


Product Indication

Argipressin based vasopressor indicated for the treatment of catecholamine refractory hypotension following septic shock in patients older than 18 years.
A catecholamine refractory/resistant hypotension is present if the mean arterial blood pressure cannot be stabilized to >65 mmHg despite adequate volume substitution and application of catecholamines.

Active Pharmaceutical Ingredient: 
Argipressin (also known as vasopressin, arginine-vasopressin, antidiuretic hormone) is a naturally produced human hormone for raising blood pressure and inducing water retention.

Summary of Product Characteristics


For detailed information about how Empressin can help improve the treatment of catecholamin resistant septic shock, please log in to our section for medical professionals

Brand names may vary by country: EMPRESSIN, EMBESIN, EMBESYN, EMPESIN, EMPRESSINE, Reverpleg


Learn more about Empressin®   and how it can support physicians in managing septic shock.